However, it is commercially distributed under alternative labels such as dietary supplements or research-use chemicals, categories that fall outside standard FDA premarket approval
As an analog of endogenous growth hormone-releasing hormone (GHRH), tesamorelin boasts a metabolism-stimulating activity that has led to its being approved as a treatment for lipodystrophy, or abnormal adipose fat accumulation associated with antiretroviral therapy for HIV.3 But this same activity can help non-HIV individuals shed abdominal fat of their own, while the peptides GHRH properties make it a suitable therapy for people looking to increase their lean mass
The most frequently reported risks include injection-site pain, redness, or swelling
In experimental mice models of Parkinsons disease, BV acupuncture therapy (BVA) was shown to protect from rotenone-triggered oxidative damage, neurological inflammation, and cytotoxicity (Mi et al., 2024)